Systematic Review

Published on 24 Feb 2022

Evolution of Immunotherapy for Ovarian Cancer from a Bird’s-Eye Perspective: A Text-Mining Analysis of Publication Trends and Topics

in Cancer Immunity and Immunotherapy

Guangyi Jiang
Junjie Hong
Feng Shao
Qiang Wen
Feng Cheng
Tunan Yu
Jianqing Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.795129

4,792 views
7 citations

Systematic Review

Published on 24 Feb 2022

An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Chaoxing Liu
Huaijuan Guo
Haiyan Mao
Jiandong Tong
Mengxue Yang
Xuebing Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.753234

4,594 views
24 citations

Review

Published on 23 Feb 2022

When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies

in Cancer Immunity and Immunotherapy

Xiaofeng Dai
Jitian Li
Yiming Chen
Kostya (Ken) Ostrikov

Frontiers in Oncology

doi 10.3389/fonc.2022.837995

2,939 views
4 citations

Case Report

Published on 22 Feb 2022

Case Report: An “Immune-Cold” EGFR Mutant NSCLC With Strong PD-L1 Expression Shows Resistance to Chemo-Immunotherapy

in Cancer Immunity and Immunotherapy

Qian Zhao
Xue Zhang
Qiang Ma
Nuo Luo
Zhulin Liu
Renyuan Wang
Yong He
Li Li

Frontiers in Oncology

doi 10.3389/fonc.2022.765997

2,921 views
5 citations

Review

Published on 17 Feb 2022

CD38: A Significant Regulator of Macrophage Function

in Cancer Immunity and Immunotherapy

Wentao Li
Yanling Li
Xi Jin
Qianjin Liao
Zhifang Chen
Honghua Peng
Yanhong Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.775649

12,461 views
34 citations

Case Report

Published on 17 Feb 2022

Case Report: Benefits of a NSCLC Patient With EGFR A289G/F287_G288insHA cis Mutations From Immunotherapy in Combination With Antiangiogenesis and Chemotherapy and Sequential Treatment of EGFR-TKI

in Cancer Immunity and Immunotherapy

He Zhang
Weiwei Dong
Huixia Zhao
Yanyan Hu
Xia You
Tingting Sun
Wenhua Xiao

Frontiers in Oncology

doi 10.3389/fonc.2022.826938

2,353 views
3 citations

Original Research

Published on 17 Feb 2022

Mesenchymal Stem Cells Inhibits Migration and Vasculogenic Mimicry in Nasopharyngeal Carcinoma Via Exosomal MiR-125a

in Cancer Immunity and Immunotherapy

Fangzhu Wan
Haojiong Zhang
Jiyi Hu
Li Chen
Shikai Geng
Lin Kong
Jiade J. Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.781979

3,086 views
4 citations

Review

Published on 16 Feb 2022

Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy

in Cancer Immunity and Immunotherapy

Yuqing Zhou
Zhaoxia Liu
Tingtao Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.847350

7,815 views
14 citations

Mini Review

Published on 15 Feb 2022

Macrophages and Metabolic Reprograming in the Tumor Microenvironment

in Cancer Immunity and Immunotherapy

Jin Liu
Mingwei Gao
Zhou Yang
Yidan Zhao
Kun Guo
Binwen Sun
Zhenming Gao
Liming Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.795159

4,154 views
13 citations

Case Report

Published on 14 Feb 2022

Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN

in Cancer Immunity and Immunotherapy

Xi Guo
Suyao Li
Hanxing Tong
Yong Zhang
Yuan Ji
Rongyuan Zhuang
Chenlu Zhang
Yang You
Weiqi Lu
Yuhong Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.802074

2,375 views
5 citations

Original Research

Published on 11 Feb 2022

Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients

in Cancer Immunity and Immunotherapy

Mahlatse C. M. Kgokolo
Katherine Anderson
Shalate C. Siwele
Helen C. Steel
Luyanda L. I. Kwofie
Mike M. Sathekge
Pieter W. A. Meyer
Bernardo L. Rapoport
Ronald Anderson

Frontiers in Oncology

doi 10.3389/fonc.2022.819790

3,477 views
6 citations

Review

Published on 10 Feb 2022

In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy

in Cancer Immunity and Immunotherapy

Tianqing Xin
Li Cheng
Chuchao Zhou
Yimeng Zhao
Zhenhua Hu
Xiaoyan Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.809754

39,684 views
49 citations

Systematic Review

Published on 09 Feb 2022

Predictive Efficacy of Blood-Based Tumor Mutation Burden Assay for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Nan Zhang
Jinwei Zhang
Guoqing Wang
Xin He
Yin Mi
Ying Cao
Xiaoxu Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.795933

3,282 views
9 citations

Original Research

Published on 08 Feb 2022

Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy

in Cancer Immunity and Immunotherapy

Huiping Qiang
Jiaqi Li
Qing Chang
Yinchen Shen
Jialin Qian
Tianqing Chu

Frontiers in Oncology

doi 10.3389/fonc.2022.835225

8,737 views
8 citations

Case Report

Published on 08 Feb 2022

Case Report: Pathological Complete Response in a Lung Metastasis of Phyllodes Tumor Patient Following Treatment Containing Peptide Neoantigen Nano-Vaccine

in Cancer Immunity and Immunotherapy

Huizi Sha
Qin Liu
Li Xie
Jie Shao
Lixia Yu
Lanqi Cen
Lin Li
Fangcen Liu
Hanqing Qian
Jia Wei

Frontiers in Oncology

doi 10.3389/fonc.2022.800484

4,210 views
6 citations

Review

Published on 07 Feb 2022

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment

in Cancer Immunity and Immunotherapy

Siting Yu
Yang Wang
Ping He
Bianfei Shao
Fang Liu
Zhongzheng Xiang
Tian Yang
Yuanyuan Zeng
Tao He
Jiachun Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.809304

13,978 views
42 citations

Navigation group

Articles

Evolution of Immunotherapy for Ovarian Cancer from a Bird’s-Eye Perspective: A Text-Mining Analysis of Publication Trends and Topics

An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis

When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies

Case Report: An “Immune-Cold” EGFR Mutant NSCLC With Strong PD-L1 Expression Shows Resistance to Chemo-Immunotherapy

CD38: A Significant Regulator of Macrophage Function

Case Report: Benefits of a NSCLC Patient With EGFR A289G/F287_G288insHA cis Mutations From Immunotherapy in Combination With Antiangiogenesis and Chemotherapy and Sequential Treatment of EGFR-TKI

Mesenchymal Stem Cells Inhibits Migration and Vasculogenic Mimicry in Nasopharyngeal Carcinoma Via Exosomal MiR-125a

Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy

Macrophages and Metabolic Reprograming in the Tumor Microenvironment

Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN

Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients

In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy

Predictive Efficacy of Blood-Based Tumor Mutation Burden Assay for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy

Case Report: Pathological Complete Response in a Lung Metastasis of Phyllodes Tumor Patient Following Treatment Containing Peptide Neoantigen Nano-Vaccine

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment